External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Metabolism Breakthrough T1D Clinical & Research Congress 2026
Roche and Genentech at

Breakthrough T1D Clinical & Research Congress 2026

October 09 - October 11
Philadelphia, USA
bt1dcongress.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
01:00 PM
Duration 60mins Philadelphia, USA
Acmopatide (CT-868), a Novel Signal-biased Dual GLP-1/GIP Receptor Agonist, Improves Quality-of-life Measures and Suppresses Hunger in Adults with Type 1 Diabetes
Brian Ulmer, Anastasia Albanese-O'Neill, Halis Akturk, Joan Ashby, Tim S. Bailey, Klara Klein, Na Li, Jeremy Pettus, Richard Pratley, Gabriele E Sonnenberg
Metabolism | Diabetes Mellitus Type I

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.